Perseus Biomics Overview
- Year Founded
-
2016

- Status
-
Private
- Employees
-
27

- Latest Deal Type
-
Series C
- (Upcoming)
- Latest Deal Amount
-
$15M
- Investors
-
3
Perseus Biomics General Information
Description
Developer of microbiome analysis technology designed to monitor the microbiome status and function and quantify its impact on all aspects of human life. The company's technology simplifies, accelerates, and democratizes microbiome analysis to precisely measure the composition and dynamics of the microbiome by uncovering its role in human health and the environment, enabling researchers to access genetic analysis devices to analyze the full genetic makeup of microbiomes.
Contact Information
Website
www.perseusbiomics.comCorporate Office
- Industriepark 6, Bus 3
- 3300 Tienen
- Belgium
Corporate Office
- Industriepark 6, Bus 3
- 3300 Tienen
- Belgium
Perseus Biomics Timeline
Perseus Biomics Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
5. Later Stage VC (Series C) | 31-Dec-2025 | $15M | Upcoming | Product In Beta Test | ||
4. Later Stage VC | 30-Jun-2024 | Completed | Product In Beta Test | |||
3. Later Stage VC (Series B) | 12-Jan-2024 | Completed | Startup | |||
2. Grant | 16-Jun-2021 | $3.04M | $2.18M | Completed | Startup | |
1. Seed Round | 02-Jun-2020 | $2.18M | $2.18M | Completed | Startup |
Perseus Biomics Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series B | ||||||||
Series B | ||||||||
Series A | 2,500 | $861.25 | $861.25 | 1x | $861.25 | 15.61% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Perseus Biomics Patents
Perseus Biomics Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20230250493-A1 | Kit and methods for characterizing a virus in a sample | Pending | 25-Jun-2020 | ||
JP-2023530751-A | Kits and methods for characterizing viruses in samples | Pending | 25-Jun-2020 |
Perseus Biomics Signals
Perseus Biomics Investors (3)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
European Innovation Council Fund | Venture Capital | Minority | ||
Kindmore | Venture Capital | Minority | ||
ZEISS Ventures | Corporate Venture Capital | Minority |
Perseus Biomics FAQs
-
When was Perseus Biomics founded?
Perseus Biomics was founded in 2016.
-
Where is Perseus Biomics headquartered?
Perseus Biomics is headquartered in Tienen, Belgium.
-
What is the size of Perseus Biomics?
Perseus Biomics has 27 total employees.
-
What industry is Perseus Biomics in?
Perseus Biomics’s primary industry is Biotechnology.
-
Is Perseus Biomics a private or public company?
Perseus Biomics is a Private company.
-
What is Perseus Biomics’s current revenue?
The current revenue for Perseus Biomics is
. -
How much funding has Perseus Biomics raised over time?
Perseus Biomics has raised $13.9M.
-
Who are Perseus Biomics’s investors?
European Innovation Council Fund, Kindmore, and ZEISS Ventures have invested in Perseus Biomics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »